Informations techniques
Exploitant
Laboratoires PROSTRAKAN PHARMA
Présentation
DROLEPTAN 2,5 mg/ 1ml, solution injectable (IV) B/10 - CIP 561 122-8
eNq1mFFv2jAQx9/5FFHeSQKlJZsC1cbaDanVGC3atJfKJEcxc+307ADdp59DqJZOztqa+g3i5H8X39+/OyU53d4xbw0oqeADvxNEvgc8FRnltwN/dn3ejv3TYStZkTWp3dYPoqDT9b2UESkHfrkazIFwGfy4vPgE+nlAf9jyEjFfQaqe3FcoyoIvRC4vSV7e4yVrQTPvDtRSZAM/L9TuqpdIhTqL4UbgL5mTFJJwf6W+urrp1a8nYSn2AtVCAl4QfmsUXaCVZlogAlcjouBW4INZOr3pxv2TKIqtQlA5BSkKTGFC1HKCYk0zyMyRCJNgFWSxya4A1wxUGcQoHq7SO2klTlZkO4X7sTnpD3p1pLaqHbU7/X7U6UVR/zg+OrEKhbWtMptHv0SY55jddN/Fx0dxP1xgmKFgkCvC2/pXDkgzwSxrNRGoCHNUJSpHT/3mKA7C/bNuyKjMGXkIVjK33SqCRC8Daiq4e5HyDa5Rc4rpPftHnxeMha/MeraniKOMS0iNRMFVA0zOp7YbMRJcwba5onb8U9u9FynIt5P9LbiZ/ZNizmhqizgNoQKkmk3HzYRzCYePRMIM3dHhO+WZ2Mi3p069yo6yz3fg/E8D7cVxbH2kfmpDNfSfs6Isa6hpROUhkBnzhTgUL9qjZqlHhzoz5244Eilh0DAetS3Jo135OM058727M1UtGEU/n13b2uVbAfhwtftrlKbZoF5oOzK7wL32Z2Pur3d7deRfMDv34qOunavRTJSlUrl8H4abzSZYEtmWRG9WoM+T6w5Qa8LuJnknnb6afCqOOkp9XrXH11XM9gw+NwscOt/un9/P0cYYCgs4oBYVrp1BdXz29pz+O9w6S3vyBCruwuwGUaKo4K4GomJuVDy4M+jS8nPUjPi6WNCGbyyN1kzC6vvOsJWE5bedYesPtOwEng==
0ys5Nqk1p4m5bHvd